I have a 1k position in the stock.
I rarely read message boards of stocks I have positions in.
Should never have been approved?
Why in the world would the FDA approve an expensive therapy
of little value?
Mblock, your response was both touching and confirmation that the drug does
It's for the individual to decide whether the expense is worth the benefit.
"you obviously didn't read or understand the sarcasm in my statement."
Oh thanks for enlightening us as to what you meant. I did not have a clue, oh great one!
Please continue to enlighten us. hehehehe.
So you are saying brain transplant success rates are high also. Man you are very smart. So please enlighten us with some more of your wisdom.
You're a moron lol. You know nothing about the drug, clearly. Nor do you know anything about the success rate of a double lung, clearly..... It isn't about total FEV1 increase. There are a lot of other things it can accomplish. But you should probably have a brain transplant, it's the only thing that will save you but don't worry i'm sure success rates are high for that too!
"Best and much cheaper is a double lung transplant."
Yes, like there are lots of lungs are waiting in line to be transplanted!!! Get real pal.
At best for $250,000 you get a 3% improvement with most patients having a difficult time with side effects. If they can tolerate the side effects, the drug loses its effectiveness after a year. Best and much cheaper is a double lung transplant.
Really? And you are basing this on what exactly? My wife is on it and hasn't needed IV medication in over 6 months now and her lung function is much more stable. She was on a schedule of needing hospitalizations every quarter and now hasn't needed it since starting the drug. I would call that a small miracle. Her life is worth any cost so go spout your garbage elsewhere.
itsalldonewithtech • 45 seconds ago Remove 0users liked this postsusers disliked this posts0Reply
Incy or Vrtx or Gwph???. Been looking at all...
Anyone who really knows this area? I've invested in Biotech's thru the years off and on and like these on recent news and chart patterns.
Ditched my old service and now I am up 5000% thanks to PennyStock101(org) Look them up in Google and sign up to their free email newsletter.
More important is the reason for the breakout. Investors may be betting on better than expected sales of orkambi in first quarter and perhaps positive guidance from vertex management at the first quarter conference call regarding the rest of the year's sales and clinical trial data release timeline from the R&D pipeline. Also takeover speculation in the sector may include Vertex as the PfizerAllergandeal unravels and these two companies start looking for alternativeacquistion candidates whose shares are currently greatly discounted and have a rich R&D pipeline of potential blockbuster drugs.